Myology research highlights
RSS feedDMD: efficacy of gene augmentation therapy through a pre-treatment with antisense oligonucleotides
Team 5 from the Institute of Myology Centre of Research, “RNA-repair based therapeutic strategies and skeletal muscle pathophysiology” directed by France Piétri-Rousel, showed in a study led and conducted by Stéphanie Lorain and Cécile Peccate that a pre-treatment made of antisense oligonucleotides improves significantly the benefit of gene therapy for Duchenne Muscular Dystrophy. This “preparation” … [Read more]
Use of hip kinetics to identify functional muscle strength in young boys with Duchenne muscular dystrophy
The success of randomized clinical trials for novel therapeutics for DMD depends on outcome measurements that are sensitive to change. As the development of motor skills may lead to functional improvements in young boys with DMD, their inclusion may potentially confound clinical trials. Three-dimensional gait analysis is an under-utilized approach that can quantify joint … [Read more]
Feasibility of ActiMyo® in recording movements of non-ambulant DMD patients
Measurement of muscle strength and activity of upper limbs of non-ambulant patients with neuromuscular diseases is a major challenge. ActiMyo® is an innovative device that uses magneto-inertial sensors to record angular velocities and linear accelerations that can be used over long periods of time in the home environment. The device was designed to insure long-term … [Read more]
Identifying a dominantly inherited pattern of calpainopathy
Limb girdle muscular dystrophy type 2A is the most common limb girdle muscular dystrophy form worldwide. Although strict recessive inheritance is assumed, patients carrying a single mutation in the calpain 3 gene (CAPN3) are reported. Such findings are commonly attributed to incomplete mutation screening. Here, the authors report on 37 individuals (age range: 21-85 … [Read more]
Misregulation of mTOR signaling in dystrophic dystroglycanopathy skeletal muscle
Secondary dystroglycanopathies are a subset of muscular dystrophy caused by abnormal glycosylation of α-dystroglycan (αDG). Loss of αDG functional glycosylation prevents it from binding to laminin and other extracellular matrix receptors, causing muscular dystrophy. Mutations in a number of genes, including FKTN (fukutin), disrupt αDG glycosylation. Here, the authors analyzed conditional Fktn knockout (Fktn KO) … [Read more]
Use of quantitative scores to differentiate demyelinating inflammatory and hereditary neuropathies
This study used ultrasound/electrophysiology of predefined nerves to differentiate between Charcot-Marie Tooth hereditary neuropathy (CMT1) and chronic inflammatory demyelinating polyradiculoneuropathies (CIDP), multifocal motor neuropathy (MMN) and multifocal acquired demyelinating sensory and motor neuropathies (MADSAM) and healthy controls. Ultrasound pattern sum score (UPSS, sum of the amount of 12 predefined measurement points), homogeneity score (HS) … [Read more]
Identification of a novel CMS gene, MYO9A
Congenital myasthenic syndromes (CMS) are a group of rare and genetically heterogenous disorders resulting from defects in the structure and function of the neuromuscular junction. Patients with congenital myasthenic syndrome exhibit fatigable muscle weakness with a variety of accompanying phenotypes depending on the protein affected. A cohort of patients with a clinical diagnosis of congenital … [Read more]
The economic burden of spinal muscular atrophy
This study used Department of Defense Military Healthcare System (MHS) data from 2003-2012 to evaluate the economic burden of spinal muscular atrophy (SMA). Healthcare costs were determined for patients with at least one inpatient or three outpatient claims with a diagnosis of SMA before 18 years of age and who had ≥ 6 months of … [Read more]
Lower-trunk accelerometry to characterize gait pattern abnormalities in patients with DM1
This study evaluated gait using lower-trunk accelerometry and investigated relationships between gait abnormalities, postural instability, handgrip myotonia, and weakness in lower-limb and axial muscle groups commonly affected in myotonic dystrophy type 1 (DM1). Twenty-two patients (11 men, 11 women; age = 42 years (range: 26-51)) with DM1 and twenty healthy controls (9 men, 11 women; age = 44 years … [Read more]
A human pluripotent stem cell model of FSHD-affected skeletal muscles
Facioscapulohumeral muscular dystrophy (FSHD) represents a major unmet clinical need arising from the progressive weakness and atrophy of skeletal muscles. The dearth of adequate experimental models has severely hampered our understanding of the disease. To date, no treatment is available for FSHD. Human embryonic stem cells (hESCs) potentially represent a renewable source of skeletal muscle … [Read more]